US2003232803A1PendingUtilityA1

Crystalline 1-methylcarbapenem derivatives

Assignee: SANKYO COPriority: Jul 6, 1999Filed: Apr 3, 2003Published: Dec 18, 2003
Est. expiryJul 6, 2019(expired)· nominal 20-yr term from priority
A61K 31/407A61P 31/04C07D 477/20A61P 31/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides crystalline forms of a 1-methylcarbapenem derivative of formula (I) or of pharmaceutically acceptable salts thereof. The crystalline forms of the 1-methylcarbapenem derivative exhibit excellent antibiotic activity against various bacterial strains and sufficient stability for practical use.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form:  
       
         
           
           
               
               
           
         
       
     
     
         2 . A 1-methylcarbapenem derivative of formula (I-1) in crystalline form:  
       
         
           
           
               
               
           
         
       
     
     
         3 . A 1-methylcarbapenem derivative of formula (I-2) in crystalline form:  
       
         
           
           
               
               
           
         
       
     
     
         4 . A 1-methylcarbapenem derivative of formula (I) in crystalline form:  
       
         
           
           
               
               
           
         
       
     
     
         5 . A 1-methylcarbapenem derivative of formula (I-3) in crystalline form:  
       
         
           
           
               
               
           
         
       
     
     
         6 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in  claim 1  as an active ingredient together with a diluent or carrier therefor.  
     
     
         7 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in  claim 2  as an active ingredient together with a diluent or carrier therefor.  
     
     
         8 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in  claim 3  as an active ingredient together with a diluent or carrier therefor.  
     
     
         9 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in  claim 4  as an active ingredient together with a diluent or carrier therefor.  
     
     
         10 . A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in  claim 5  as an active ingredient together with a diluent or carrier therefor.  
     
     
         11 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in  claim 1 .  
     
     
         12 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in  claim 2 .  
     
     
         13 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in  claim 3 .  
     
     
         14 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in  claim 4 .  
     
     
         15 . A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in  claim 5.

Join the waitlist — get patent alerts

Track US2003232803A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.